Filing metadata

Accession number
0001127602-20-030293
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Dec 02, 2020
Reporting period
Dec 01, 2020
Description
Insider transaction

Explore SEC Filings Hub